Explore All Access
Check if your research matches the topics covered in Wspolczesna Onkologia?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Wspolczesna Onkologia : Impact Factor & More
eISSN: 1897-4309pISSN: 1428-2526
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Wspolczesna Onkologia Key Metrics
CiteScore 
2.8
SJR
Q3Oncology
SNIP
0.61
Topics Covered on Wspolczesna Onkologia
Cancer
Overall survival
Breast cancer
Fibulin
Myasthenia gravis
Chemoradiotherapy
Ovarian cancer
Colorectal cancer
Lymph node metastasis
Renal carcinoma
Progression-free survival
Cross-sectional study
Hepatocellular carcinoma
Lung cancer
Immunotherapy
Cardiac tamponade
Dermatomyositis
Pulmonary tumor embolism
Prognostic biomarker
Tamoxifen
Wspolczesna Onkologia Journal Specifications
| Overview | |
| Publisher | TERMEDIA PUBLISHING HOUSE LTD |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | EUR 200 |
| Publication Time | 24 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 1987 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 24 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY-NC-SA |
| OA statement | Visit website |
View less
Planning to publish in Wspolczesna Onkologia ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Wspolczesna Onkologia
Performance of ChatGPT in providing patient information about upper tract urothelial carcinoma.
- 1 Jan 2024
- Contemporary oncology (Poznan, Poland)
Downregulation of the keratins CK13 and CK14 does not significantly affect cell viability of human urinary bladder carcinoma cells.
- 1 Jan 2024
- Contemporary oncology (Poznan, Poland)
Core needle biopsy: an efficacious adjunct to cytological diagnosis in thyroid tumours suspected of anaplastic carcinoma - single-centre experience.
- 1 Jan 2024
- Contemporary oncology (Poznan, Poland)
Clinicopathological significance of protein disulphide isomerase A3 and phosphorylated signal transducer and activator of transcription 3 in cervical carcinoma
- 1 Jan 2024
- Współczesna Onkologia
Cytotoxic activity of Fomitopsis betulina against normal and cancer cells - a comprehensive literature review.
- 1 Jan 2024
- Contemporary oncology (Poznan, Poland)
The antitumour efficacy of hesperidin vs. cisplatin against non-small lung cancer cells A549 and H460 via targeting the miR-34a/PD-L1/NF-κB signalling pathway.
- 1 Jan 2024
- Contemporary oncology (Poznan, Poland)
Performance of ChatGPT in providing patient information about upper tract urothelial carcinoma.
- 1 Jan 2024
- Contemporary oncology (Poznan, Poland)
Downregulation of the keratins CK13 and CK14 does not significantly affect cell viability of human urinary bladder carcinoma cells.
- 1 Jan 2024
- Contemporary oncology (Poznan, Poland)
Core needle biopsy: an efficacious adjunct to cytological diagnosis in thyroid tumours suspected of anaplastic carcinoma - single-centre experience.
- 1 Jan 2024
- Contemporary oncology (Poznan, Poland)
Clinicopathological significance of protein disulphide isomerase A3 and phosphorylated signal transducer and activator of transcription 3 in cervical carcinoma
- 1 Jan 2024
- Współczesna Onkologia
Cytotoxic activity of Fomitopsis betulina against normal and cancer cells - a comprehensive literature review.
- 1 Jan 2024
- Contemporary oncology (Poznan, Poland)
The antitumour efficacy of hesperidin vs. cisplatin against non-small lung cancer cells A549 and H460 via targeting the miR-34a/PD-L1/NF-κB signalling pathway.
- 1 Jan 2024
- Contemporary oncology (Poznan, Poland)
Compare Similar Journals with Wspolczesna Onkologia
Select Journals to Compare with Wspolczesna Onkologia
Total journals - 10
You can select up to 3 Journals at a time
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Annals of Oncology
Publisher: ELSEVIER
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
BMC Cancer
Publisher: BMC
Cancers
Publisher: MDPI
Medicine
Publisher: Elsevier
Cancer Management and Research
Publisher: DOVE MEDICAL PRESS LTD
Oncology Letters
Publisher: SPANDIDOS PUBL LTD
Oncotarget
Publisher: Impact Journals
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
0 Journals Selected to compare with
Wspolczesna Onkologia
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Wspolczesna Onkologia
How long has Wspolczesna Onkologia been actively publishing? 
Wspolczesna Onkologia has been in operation since 1987 till date.
What is the publishing frequency of Wspolczesna Onkologia?
Wspolczesna Onkologia published with a Quarterly frequency.
How many articles did Wspolczesna Onkologia publish last year?
In 2023, Wspolczesna Onkologia publsihed 41 articles.
What is the eISSN & pISSN for Wspolczesna Onkologia?
For Wspolczesna Onkologia, eISSN is 1897-4309 and pISSN is 1428-2526.
What is Citescore for Wspolczesna Onkologia?
Citescore for Wspolczesna Onkologia is 2.8.
What is SNIP score for Wspolczesna Onkologia?
SNIP score for Wspolczesna Onkologia is 0.61.
What is the SJR for Wspolczesna Onkologia?
SJR for Wspolczesna Onkologia is Q3.
Who is the publisher of Wspolczesna Onkologia?
TERMEDIA PUBLISHING HOUSE LTD is the publisher of Wspolczesna Onkologia.
